https://www.selleckchem.com/pr....oducts/jh-x-119-01.h
More impressively, the ratios were significantly higher in 16 patients with progression of PM within 1year compared with 27 patients with an excellent tumor response (miR-21-5p/miR-29b-3p median 17.49, range 1.83-50.90 vs. median 4.64, range 0.40-38.96, p = 0.0015, miR-223-3p/miR-29b-3p median 1.02, range 0.23-25.85 vs. median 0.21, range 0.01-50.07, p = 0.0006). Overall survival of patients with high miR-21/miR-29b or miR-223/miR-29b ratios was significantly worse than in patients with low ratios (p = 0.0117, p = 0.0021). The ratio
Like
Comment
Share
